Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Perspectives in Diabetes

Neuronal Glucosensing

What Do We Know After 50 Years?

  1. Barry E. Levin12,
  2. Vanessa H. Routh3,
  3. Ling Kang2,
  4. Nicole M. Sanders4 and
  5. Ambrose A. Dunn-Meynell12
  1. 1Neurology Service, Department of Veterans Affairs New Jersey Health Care System, East Orange, New Jersey
  2. 2Department of Neurology and Neurosciences, New Jersey Medical School, University of Medicine and Dentistry, Newark, New Jersey
  3. 3Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry, Newark, New Jersey
  4. 4Metabolism/Endocrinology Service, VA Puget Sound Health Care System, Seattle, Washington
  1. Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), Department of Veterans Affairs NJ Health Care System, 385 Tremont Ave., E. Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu
Diabetes 2004 Oct; 53(10): 2521-2528. https://doi.org/10.2337/diabetes.53.10.2521
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Location of ARC and VMN neurons relative to blood, CSF, and brain glucose levels. ARC neurons are potentially exposed to glucose from the CSF, which diffuses across the β1-tanycytes lining the IIIrd cerebral ventricle; blood glucose, which diffuses across the fenestrated capillaries in the median eminence; and glucose, which is transported across the blood-brain barrier. Some of these neurons synapse with VMN neurons, which are exposed primarily to glucose transported from blood and diffusing from CSF.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Hypothetical model of a GE neuron and its relationship to adjacent astrocytes. Glucose is transported across the microvessel by GLUT1 and enters either the astrocyte by GLUT1 transport or the extracellular space, where it is transported into a GE neuron by GLUT3. GK is localized together with adjacent mitochondria beneath the plasma membrane containing a KATP channel. ATP formed in this microenvironment binds to the KATP channel, which inactivates (closes) the channel leading to membrane depolarization, entry of calcium through a voltage-dependent calcium channel (VDCC), and, in many cases, increased neuronal activity. Local changes in ambient glucose concentrations at the axon terminal can also inactivate KATP channels with release of neurotransmitters such as glutamate. Hexokinase I (HKI) regulates the formation of ATP for general metabolic functions of the neurons. Glucose transported into astrocytes is stored as glycogen. Glycogenolysis produces lactate that is transported by an MCT1 transporter into the extracellular space and then into the neuron through MCT1. This lactate is converted to pyruvate by LDH and oxidized in the mitochondria with resultant ATP production. Under low ambient glucose conditions, this astrocyte-derived lactate can raise neuronal ATP levels sufficiently to close the KATP channel, leading to neuronal activation.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Leptin (Lep) increases intracellular calcium oscillations in a dissociated VMN GE neuron that expresses the OB-Rb receptor. Addition of 10 nmol/l leptin to a GE neuron that was inactive at 0.5 mmol/l glucose (G) leads to activation (increased intracellular Ca+2 oscillations). Single-cell RT-PCR of the cytoplasmic contents of this neuron demonstrated that it expressed mRNA for GK, the signaling form of the leptin receptor (OB-Rb), the insulin receptor (INS-R), GLUT3, and GAD (which defines it as GABAergic) (23,96).

PreviousNext
Back to top

In this Issue

October 2004, 53(10)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neuronal Glucosensing
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neuronal Glucosensing
Barry E. Levin, Vanessa H. Routh, Ling Kang, Nicole M. Sanders, Ambrose A. Dunn-Meynell
Diabetes Oct 2004, 53 (10) 2521-2528; DOI: 10.2337/diabetes.53.10.2521

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Neuronal Glucosensing
Barry E. Levin, Vanessa H. Routh, Ling Kang, Nicole M. Sanders, Ambrose A. Dunn-Meynell
Diabetes Oct 2004, 53 (10) 2521-2528; DOI: 10.2337/diabetes.53.10.2521
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • GLUCOSENSING NEURONS INTEGRATE A VARIETY OF TIME- AND CONCENTRATION-DEPENDENT PATTERNS OF GLUCOSE CHANGE
    • HOW IS GLUCOSE SENSED?
    • GLUCOSENSING NEURONS AS METABOLIC SENSORS
    • WHAT PHYSIOLOGICAL FUNCTIONS ARE REGULATED BY GLUCOSENSING NEURONS?
    • HOW IS GLUCOSENSING ALTERED BY DISEASE?
    • SUMMARY AND CONCLUSIONS: WHAT HAVE WE LEARNED AND WHAT REMAINS TO BE LEARNED?
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Regulation of Hepatic Metabolism and Cell Growth by the ATF/CREB Family of Transcription Factors
  • Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes
  • Emerging Role of Bone Morphogenetic Protein 4 in Metabolic Disorders
Show more Perspectives in Diabetes

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.